Medicenna Therapeutics Corp. (TSE:MDNA – Get Free Report) shares traded up 0.6% during mid-day trading on Thursday . The company traded as high as C$1.91 and last traded at C$1.70. 102,231 shares were traded during mid-day trading, a decline of 5% from the average session volume of 107,412 shares. The stock had previously closed at C$1.69.
Medicenna Therapeutics Stock Up 0.6 %
The firm has a market capitalization of C$129.93 million, a price-to-earnings ratio of -4.47 and a beta of 1.21. The business has a 50 day simple moving average of C$2.16 and a 200-day simple moving average of C$2.19. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.65 and a current ratio of 2.51.
Medicenna Therapeutics Company Profile
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors.
See Also
- Five stocks we like better than Medicenna Therapeutics
- Upcoming IPO Stock Lockup Period, Explained
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What are earnings reports?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What Are Trending Stocks? Trending Stocks Explained
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Medicenna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicenna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
